These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 8623221)

  • 1. Long-term and multilineage bone marrow reconstitution in normal untreated recipients.
    Taniguchi H; Yuzawa K; Otsuka M; Fukao K; Nakauchi H
    Transplant Proc; 1996 Apr; 28(2):1042-4. PubMed ID: 8623221
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients.
    Westerhof GR; Ploemacher RE; Boudewijn A; Blokland I; Dillingh JH; McGown AT; Hadfield JA; Dawson MJ; Down JD
    Cancer Res; 2000 Oct; 60(19):5470-8. PubMed ID: 11034090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac allograft acceptance after localized bone marrow transplantation by isolated limb perfusion in nonmyeloablated recipients.
    Askenasy N; Yolcu ES; Shirwan H; Wang Z; Farkas DL
    Stem Cells; 2003; 21(2):200-7. PubMed ID: 12634416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of treosulfan to a nonmyeloablative conditioning regimen results in enhanced chimerism and immunologic tolerance in an experimental allogeneic bone marrow transplant model.
    Ploemacher RE; Johnson KW; Rombouts EJ; Etienne K; Westerhof GR; Baumgart J; White-Scharf ME; Down JD
    Biol Blood Marrow Transplant; 2004 Apr; 10(4):236-45. PubMed ID: 15077222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow transplantation and medulla architecture reconstitution in the murine thymus.
    Iclozan C
    Hokkaido Igaku Zasshi; 2005 Mar; 80(2):239-43, 245-9. PubMed ID: 15835303
    [No Abstract]   [Full Text] [Related]  

  • 6. Application of chimerism-based drug-induced tolerance to rat into mouse xenotransplantation.
    Tomita Y; Shimizu I; Iwai T; Zhang QW; Okano S; Kajiwara T; Onzuka T; Tominaga R
    Scand J Immunol; 2006 Oct; 64(4):392-7. PubMed ID: 16970680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of natural killer cell depletion on long-term multilineage allogeneic bone marrow engraftment.
    Lee LA; Sachs DH; Sykes M
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1246-7. PubMed ID: 8442104
    [No Abstract]   [Full Text] [Related]  

  • 8. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance induction through megadose bone marrow transplantation with two-signal blockade.
    Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Kwon CH; Joh JW; Kim SJ
    J Surg Res; 2006 Jan; 130(1):102-9. PubMed ID: 16183077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of pretreatment with donor antigen and immunosuppressive agents on fully allogenic tracheal graft.
    Suemitsu R; Yoshino I; Shoji F; Yamaguchi M; Tomita Y; Maehara Y
    J Surg Res; 2004 Nov; 122(1):8-13. PubMed ID: 15522308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
    Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S
    Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facilitating cells enable engraftment of purified fetal liver stem cells in allogeneic recipients.
    Gaines BA; Colson YL; Kaufman CL; Ildstad S
    Exp Hematol; 1996 Jul; 24(8):902-13. PubMed ID: 8690049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absent mRNA accumulation of Th1 or Th2 cytokines in heart allografts with chimerism-based drug-induced tolerance.
    Tomita Y; Zhang QW; Matsuzaki G; Shimizu I; Iwai T; Okano S; Nomoto K; Yasui H
    Surg Today; 2005; 35(5):364-70. PubMed ID: 15864417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CD40L monoclonal antibodies can replace anti-CD4 monoclonal antibodies for the nonmyeloablative induction of mixed xenogeneic chimerism.
    Ito H; Takeuchi Y; Shaffer J; Sykes M
    Transplantation; 2006 Jul; 82(2):251-7. PubMed ID: 16858289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin and T cell costimulatory blockade as post-transplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy.
    Wu T; Sozen H; Luo B; Heuss N; Kalscheuer H; Lan P; Sutherland DE; Hering BJ; Guo Z
    Bone Marrow Transplant; 2002 Jun; 29(12):949-56. PubMed ID: 12098061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward a myeloablative regimen with clinical potential: II. Treosulfan induces specific skin graft tolerance across haploidentical MHC barriers.
    van Pel M; van Breugel DW; Vos W; Ploemacher RE; Boog CJ
    Bone Marrow Transplant; 2004 Jan; 33(2):153-9. PubMed ID: 14661037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival of xenogeneic heart grafts achieved by costimulatory blockade and transient mixed chimerism.
    Murakami M; Ito H; Harada E; Enoki T; Sykes M; Hamano K
    Transplantation; 2006 Jul; 82(2):275-81. PubMed ID: 16858292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD45 congenic bone marrow transplantation: evidence for T cell-mediated immunity.
    Xu H; Exner BG; Chilton PM; Schanie C; Ildstad ST
    Stem Cells; 2004; 22(6):1039-48. PubMed ID: 15536194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards a myeloablative regimen with clinical potential: I. Treosulfan conditioning and bone marrow transplantation allow induction of donor-specific tolerance for skin grafts across full MHC barriers.
    van Pel M; van Breugel DW; Vos W; Ploemacher RE; Boog CJ
    Bone Marrow Transplant; 2003 Jul; 32(1):15-22. PubMed ID: 12815473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.